Works matching DE "DRUG efficacy"

Results: 5000
    1
    2
    3
    4
    5
    6
    7

    Efficacy of Dose Escalation of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

    Published in:
    Medical Principles & Practice, 2025, v. 34, n. 3, p. 226, doi. 10.1159/000543831
    By:
    • Rehman, Mohammad Ebad Ur;
    • Tahir, Ammara;
    • Hussain, Amna;
    • Ali, Aizaz;
    • Bin Gulzar, Abu Huraira;
    • Khan, Abdul Qadeer;
    • Sajjad, Maha;
    • Shahid, Fatima;
    • Zahid, Shahroon;
    • Aslam, Ummara;
    • Yasin, Talha Bin;
    • Bilal, Aqsa;
    • Fatima, Tehreem;
    • Hameed, Muhammad Sheraz;
    • Haider, Tehseen;
    • Saeed, Sajeel;
    • Nashwan, Abdulqadir J.
    Publication type:
    Article
    8

    Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1581153
    By:
    • Grudzinska-Goebel, Joanna;
    • Benstein, Karin;
    • Bloem, Karien;
    • Cowan, Kyra J.;
    • Gorovits, Boris;
    • Jadhav, Maria;
    • Janssen, Melody;
    • Jawa, Vibha;
    • Kiessling, Andrea;
    • Kramer, Daniel;
    • Kromminga, Arno;
    • van der Linden, Marcel;
    • Liu, Susana;
    • Lotz, Gregor P.;
    • Luo, Linlin;
    • Malisauskas, Mantas;
    • Marban-Doran, Céline;
    • Mytych, Daniel T.;
    • Oquendo Cifuentes, Elisa;
    • Pippig, Susanne
    Publication type:
    Article
    9
    10

    Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial Open Access.

    Published in:
    Rheumatology, 2025, v. 64, n. 6, p. 3863, doi. 10.1093/rheumatology/keaf122
    By:
    • Geetha, Duvuru;
    • Pagnoux, Christian;
    • Sattui, Sebastian E;
    • Merkel, Peter A;
    • Weiner, Maria;
    • Draibe, Juliana;
    • Faguer, Stanislas;
    • Bray, Sarah;
    • Gurlin, Rachel E;
    • Balcells-Oliver, Monica;
    • Bruchfeld, Annette;
    • Jayne, David R;
    • Group, ADVOCATE Study
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease.

    Published in:
    Rheumatology, 2025, v. 64, n. 6, p. 3396, doi. 10.1093/rheumatology/keaf050
    By:
    • Yoshimura, Yusuke;
    • Yamanouchi, Masayuki;
    • Koizumi, Ryo;
    • Mizuno, Hiroki;
    • Oba, Yuki;
    • Kurihara, Shigekazu;
    • Suwabe, Tatsuya;
    • Tsunoda, Susumu;
    • Kishioka, Ayumi;
    • Takeuchi, Toshihiro;
    • Tanimizu, Hikaru;
    • Kamido, Hisashi;
    • Yoshimoto, Masatoshi;
    • Sugimoto, Hisashi;
    • Ikuma, Daisuke;
    • Tanaka, Kiho;
    • Inoue, Noriko;
    • Sekine, Akinari;
    • Hasegawa, Eiko;
    • Wada, Takehiko
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    In This Issue.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 1, doi. 10.1002/art.43190
    Publication type:
    Article
    26

    Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low‐Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 615, doi. 10.1002/art.43073
    By:
    • Gjefsen, Elisabeth;
    • Bråten, Lars C.;
    • Ponzi, Erica;
    • Dagestad, Magnhild H.;
    • Marchand, Gunn H.;
    • Kadar, Thomas;
    • Bakland, Gunnstein;
    • Haugen, Anne J.;
    • Granviken, Fredrik;
    • Flørenes, Tonje W.;
    • Vetti, Nils;
    • Grøvle, Lars;
    • Nilsen, Aksel T.;
    • Lunestad, Astrid;
    • Holmgard, Thor E.;
    • Valberg, Morten;
    • Bolstad, Nils;
    • Espeland, Ansgar;
    • Brox, Jens I.;
    • Goll, Guro L.
    Publication type:
    Article
    27

    Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 560, doi. 10.1002/art.43059
    By:
    • Dörner, Thomas;
    • Bowman, Simon J.;
    • Fox, Robert;
    • Mariette, Xavier;
    • Papas, Athena;
    • Grader‐Beck, Thomas;
    • Fisher, Benjamin A.;
    • Barcelos, Filipe;
    • De Vita, Salvatore;
    • Schulze‐Koops, Hendrik;
    • Moots, Robert J.;
    • Junge, Guido;
    • Woznicki, Janice;
    • Sopala, Monika;
    • Avrameas, Alexandre;
    • Luo, Wen‐Lin;
    • Hueber, Wolfgang
    Publication type:
    Article
    28
    29
    30
    31

    biogrowleR: Enhancing Longitudinal Data Analysis.

    Published in:
    Journal of Mammary Gland Biology & Neoplasia, 2025, v. 30, n. 1, p. 1, doi. 10.1007/s10911-025-09583-7
    By:
    • Ronchi, Carlos;
    • Ambrosini, Giovanna;
    • Hughes, Flavia;
    • Flaherty, Renée L.;
    • Quinn, Hazel M.;
    • Matvienko, Daria;
    • Agnoletto, Andrea;
    • Brisken, Cathrin
    Publication type:
    Article
    32
    33

    Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutation.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf062
    By:
    • Hernández, Isaac Nuñez;
    • Palmero, Cristina Gómez;
    • Delgado, Juan Ramón;
    • Nuño, Ana;
    • González, Maria Ángeles Sala;
    • Ageitos, Ana González;
    • Aguilar, Héctor;
    • Miguel, Pablo Ayala de;
    • Condori, Elizabeth;
    • Beveridge, Roberto Díaz;
    • García, Jerónimo Martínez;
    • Marquina, Gloria;
    • Varela-Pose, Vanesa;
    • Rodríguez, Joel Veas;
    • Serrano, César
    Publication type:
    Article
    34
    35
    36
    37

    Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf048
    By:
    • Ueno, Naoto T;
    • Cottone, Francesco;
    • Dunton, Kyle;
    • Jacot, William;
    • Yamashita, Toshinari;
    • Sohn, Joohyuk;
    • Tokunaga, Eriko;
    • Prat, Aleix;
    • Tsurutani, Junji;
    • Park, Yeon Hee;
    • Rugo, Hope S;
    • Xu, Binghe;
    • Cardoso, Fatima;
    • Mitri, Zahi;
    • Mahtani, Reshma;
    • Aguilar, Cecilia Orbegoso;
    • Xiao, Feng;
    • Harbeck, Nadia;
    • Cameron, David A;
    • Modi, Shanu
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50